Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review
Br J Surg
.
2024 Nov 27;111(12):znae284.
doi: 10.1093/bjs/znae284.
Authors
Ricardo V Cohen
1
,
Ji Yeon Park
2
3
,
Gerhard Prager
4
,
Marco Bueter
5
,
Carel W le Roux
6
,
Chetan Parmar
7
,
Mohammad Kermansaravi
8
,
Paulina Salminen
9
10
,
Alexander D Miras
11
Affiliations
1
The Center for Obesity and Diabetes, Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil.
2
Department of Surgery, School of Medicine, Kyungpook National University, Daegu, Korea.
3
Department of Surgery, Kyungpook National University Chilgok Hospital, Daegu, Korea.
4
Division of Visceral Surgery, Department of General Surgery, Vienna Medical University, Vienna, Austria.
5
Department of Surgery and Transplantation, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
6
Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
7
Bariatric and Emergency Surgery, Whittington Hospital, University College London, London, UK.
8
Minimally Invasive and Bariatric Surgery, Hazrate Rasool Akram Hospital at Iran University of Medical Sciences, Tehran, Iran.
9
Department of Surgery, University of Turku, Turku, Finland.
10
Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland.
11
School of Medicine, Ulster University, Derry, UK.
PMID:
39612581
DOI:
10.1093/bjs/znae284
No abstract available